Eli Lilly & Co. (LLY)

903.02 -16.88 (-1.84%) USD  |  NYSE  |  Apr 21, 16:00
908.92 +5.90 (+0.65%) Pre-Market: 08:26
More

Eli Lilly Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade
Apellis Pharmaceuticals, Inc. Upgrade
Arcellx, Inc. Upgrade
Moderna, Inc. Upgrade